372 related articles for article (PubMed ID: 17234718)
1. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
Patel V; Rosenfeldt HM; Lyons R; Servitja JM; Bustelo XR; Siroff M; Gutkind JS
Carcinogenesis; 2007 Jun; 28(6):1145-52. PubMed ID: 17234718
[TBL] [Abstract][Full Text] [Related]
2. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma.
Lai SY; Ziober AF; Lee MN; Cohen NA; Falls EM; Ziober BL
Oral Oncol; 2008 Jul; 44(7):683-8. PubMed ID: 17996485
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma.
Thomas SM; Bhola NE; Zhang Q; Contrucci SC; Wentzel AL; Freilino ML; Gooding WE; Siegfried JM; Chan DC; Grandis JR
Cancer Res; 2006 Dec; 66(24):11831-9. PubMed ID: 17178880
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor-stimulated activation of phospholipase Cgamma-1 promotes invasion of head and neck squamous cell carcinoma.
Thomas SM; Coppelli FM; Wells A; Gooding WE; Song J; Kassis J; Drenning SD; Grandis JR
Cancer Res; 2003 Sep; 63(17):5629-35. PubMed ID: 14500405
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
[TBL] [Abstract][Full Text] [Related]
6. Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.
Squarize CH; Castilho RM; Sriuranpong V; Pinto DS; Gutkind JS
Neoplasia; 2006 Sep; 8(9):733-46. PubMed ID: 16984731
[TBL] [Abstract][Full Text] [Related]
7. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.
Yang F; Zeng Q; Yu G; Li S; Wang CY
Cell Signal; 2006 May; 18(5):679-87. PubMed ID: 16084063
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole.
Wu Y; Palad AJ; Wasilenko WJ; Blackmore PF; Pincus WA; Schechter GL; Spoonster JR; Kohn EC; Somers KD
Clin Cancer Res; 1997 Nov; 3(11):1915-21. PubMed ID: 9815580
[TBL] [Abstract][Full Text] [Related]
9. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer.
Kudo Y; Ogawa I; Kitajima S; Kitagawa M; Kawai H; Gaffney PM; Miyauchi M; Takata T
Cancer Res; 2006 Jul; 66(14):6928-35. PubMed ID: 16849536
[TBL] [Abstract][Full Text] [Related]
10. Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma.
Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Hu WY; Chou SH; Liu CJ; Lo JF
J Pathol; 2009 Nov; 219(3):347-55. PubMed ID: 19681071
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
12. Identification of H-Ras, RhoA, Rac1 and Cdc42 responsive genes.
Teramoto H; Malek RL; Behbahani B; Castellone MD; Lee NH; Gutkind JS
Oncogene; 2003 May; 22(17):2689-97. PubMed ID: 12730683
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor biology in head and neck cancer.
Kalyankrishna S; Grandis JR
J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281
[TBL] [Abstract][Full Text] [Related]
14. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion.
Guo F; Zheng Y
Oncogene; 2004 Jul; 23(33):5577-85. PubMed ID: 15122327
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I; Grall D; Cagnol S; Stanchi F; Sudaka A; Brunstein MC; Bozec A; Fischel JL; Milano G; Van Obberghen-Schilling E
Acta Oncol; 2008; 47(8):1502-12. PubMed ID: 18607838
[TBL] [Abstract][Full Text] [Related]
16. VAV2 regulates epidermal growth factor receptor endocytosis and degradation.
Thalappilly S; Soubeyran P; Iovanna JL; Dusetti NJ
Oncogene; 2010 Apr; 29(17):2528-39. PubMed ID: 20140013
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
Yamazaki D; Kurisu S; Takenawa T
Oncogene; 2009 Apr; 28(13):1570-83. PubMed ID: 19234490
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas.
Murugan AK; Hong NT; Fukui Y; Munirajan AK; Tsuchida N
Int J Oncol; 2008 Jan; 32(1):101-11. PubMed ID: 18097548
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and activation of the Rac1 and Cdc42 GEF Asef in A431 cells stimulated by EGF.
Itoh RE; Kiyokawa E; Aoki K; Nishioka T; Akiyama T; Matsuda M
J Cell Sci; 2008 Aug; 121(Pt 16):2635-42. PubMed ID: 18653540
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Sheikh Ali MA; Gunduz M; Nagatsuka H; Gunduz E; Cengiz B; Fukushima K; Beder LB; Demircan K; Fujii M; Yamanaka N; Shimizu K; Grenman R; Nagai N
Cancer Sci; 2008 Aug; 99(8):1589-94. PubMed ID: 18754871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
